LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

LLY

966.35

+1.98%↑

JNJ

221.39

+0.12%↑

ABBV

202.82

+0.84%↑

UNH

384.32

+1.29%↑

AZN

181.82

-0.27%↓

Inicio・Lista de Acciones・NeoGenomics Inc

NeoGenomics Inc

Cerrado

8.63 -3.68

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

8.57

Máximo

8.96

Métricas clave
By Trading Economics
Ingresos	-7.2M -17M
Ventas	-3.5M 187M
BPA	0.01
Margen de beneficios	-9.164
Empleados	2,500
EBITDA	-5.8M -567K

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+66.74% upside

Dividendos
By Dow Jones
Próximas Ganancias	28 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	51M 1.2B
Apertura anterior	12.31
Cierre anterior	8.63

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

7.7 / 10.27 Soporte y Resistencia

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 may 2026, 21:03 UTC

Ganancias

Coinbase Global Swings to Loss Amid Softer Crypto Market

11 may 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

11 may 2026, 20:32 UTC

Ganancias

CleanSpark 2Q Loss/Shr $1.52 >CLSK

11 may 2026, 20:32 UTC

Ganancias

CleanSpark 2Q Rev $136.4M >CLSK

11 may 2026, 17:42 UTC

Charlas de Mercado

Zcash Gives Back Some Big Gains From Recent Days -- Market Talk

11 may 2026, 17:24 UTC

Ganancias

Circle Internet Stock Rockets After Earnings. The Stablecoin Company Is Betting on AI. -- Barrons.com

11 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

11 may 2026, 15:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

11 may 2026, 15:35 UTC

Charlas de Mercado

Altcoins Gain Traction, CoinMarketCap Index Shows -- Market Talk

11 may 2026, 15:20 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

11 may 2026, 15:20 UTC

Charlas de Mercado

Bitcoin Holds Over $80K Even With ETF Outflows -- Market Talk

11 may 2026, 14:37 UTC

Ganancias

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stablecoin Company Is Betting on AI. -- Barrons.com

11 may 2026, 13:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

11 may 2026, 12:44 UTC

Charlas de Mercado

Iran War Tensions Have Mixed Implications For Bitcoin -- Market Talk

11 may 2026, 11:27 UTC

Ganancias

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stablecoin Company Is Betting on AI. -- Barrons.com

11 may 2026, 10:40 UTC

Ganancias

Circle Internet Posts Earnings Beat but a Revenue Miss. The Stock Is Falling. -- Barrons.com

11 may 2026, 08:13 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

11 may 2026, 08:13 UTC

Charlas de Mercado

Bitcoin Steady as Investors Brush Aside Iran War Tensions -- Market Talk

8 may 2026, 17:04 UTC

Charlas de Mercado

Zcash Caps Off Parabolic Week -- Market Talk

8 may 2026, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

8 may 2026, 15:20 UTC

Charlas de Mercado

'Altcoin Season' Indicator on the Rise -- Market Talk

8 may 2026, 15:05 UTC

Charlas de Mercado

Bitcoin Slips Back Below the $80k Mark -- Market Talk

8 may 2026, 12:19 UTC

Ganancias

Bitcoin Price Dives Below $80,000. This Jobs Report Could End the Crypto Slump. -- Barrons.com

8 may 2026, 10:55 UTC

Charlas de Mercado

Bitcoin Edges Higher as Risk Sentiment Improves Slightly -- Market Talk

8 may 2026, 08:41 UTC

Ganancias

Coinbase Misses Earnings and Revenue Estimates. The Stock Is Falling. -- Barrons.com

8 may 2026, 06:25 UTC

Charlas de Mercado

Bitcoin Falls as U.S. and Iran Trade Attacks -- Market Talk

7 may 2026, 21:25 UTC

Ganancias

IREN 4Q Rev $144.80M >IREN

7 may 2026, 20:22 UTC

Ganancias

Coinbase Misses on Earnings and Revenue. The Stock Is Falling. -- Barrons.com

7 may 2026, 14:30 UTC

Charlas de Mercado

Tokenized Assets Saw 22% Market Cap Jump in April -- Market Talk

7 may 2026, 14:25 UTC

Charlas de Mercado

Stablecoin Market Cap Finds New High in April -- Market Talk

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

66.74% repunte

Estimación a 12 Meses

Media 14.94 USD 66.74%

Máximo 25 USD

Mínimo 11 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

Comprar

Mantener

Vender

De acuerdo con 12 analistas que ofrecen calificaciones bursátiles a para NeoGenomics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

7.7 / 10.27Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.